| For
applications in pharmaceutical industry, Polaris prepares and
carries out the verifications foreseen for FDA validation of
the system.
In particular, during design
phase the Functional and Design Specifications are prepared
on the basis of the client URS, which, together with other
design documents, are the basis for the successive qualification
activities.
All the design, in particular
for system that have direct impact on the customer production,
like solvent recovery units for internal use, is made taking
into account the matters related to the final validation phase
to which the system shall be submitted after installation.
In particular way the managing system and the section of the
plant related to the product control before reuse are adequately
configured.
At the end of the prefabrication
activities, the qualification protocols are prepared (IQ,
PQ). Such documents shall be checked and approved by the client
QA.
Before the plant start-up all
the verifications foreseen by the protocols are carried out,
both for installation aspects as well as the functionality
and the calibration of the elements included in the system
are concerned.
In this way several units supplied
by Polaris have successfully passed the validation by FDA.
For a constant update about
GMP and FDA norms, Polaris is associated to ISPE (International
Society for Pharmaceutical Engineering).
|